Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer
This study is currently recruiting participants.
Study NCT00475085 Information provided by National Cancer Institute (NCI)
First Received: May 16, 2007 Last Updated: June 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Nausea and Vomiting
Additional conditions recognized in this trial
Breast Neoplasms
Nausea
Vomiting
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Signs and Symptoms
Signs and Symptoms, Digestive
Skin Diseases
Interventions listed in this trial
aprepitant
dexamethasone
granisetron hydrochloride
palonosetron hydrochloride
prochlorperazine
placebo
Additional drug interventions recognized in this trial
Dexamethasone acetate
Granisetron
Palonosetron
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Rochester
National Cancer Institute (NCI)
Back to top of Main Content
